Dr Alvaro Pascual-Leone joins Vycor Medical's NovaVision
This article was originally published in Scrip
Dr Alvaro Pascual-Leone has joined NovaVision, a subsidiary of Vycor Medical, as head of the strategic advisory board. Dr Pascual-Leone, who has won many scientific awards, is professor of neurology at Harvard Medical School, director of the Berenson-Allen Center for Noninvasive Brain Stimulation, programme director of the Harvard-Thorndike Clinical Research Unit and an attending neurologist at Beth Israel Deaconess Medical Center.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.